| Ms Jacqueline Marie Martin, CRNA, MS | |
|
950 Campbell Ave, West Haven, CT 06516-2770 | |
| (203) 932-5711 | |
| Not Available |
| Full Name | Ms Jacqueline Marie Martin |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 950 Campbell Ave, West Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023011434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 2152 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jacqueline Marie Martin, CRNA, MS 35 Killdeer Rd, Hamden, CT 06517-3529 Ph: (203) 407-3960 | Ms Jacqueline Marie Martin, CRNA, MS 950 Campbell Ave, West Haven, CT 06516-2770 Ph: (203) 932-5711 |
News Archive
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern. The major factor impeding efforts to control HBV and HCV is lack of knowledge and awareness among health care providers, social service professionals, members of the public, and policy-makers.
Burgeoning consumer demand for dental implants has prompted dentists nationwide to add implants to their practices, and some have mounted aggressive advertising campaigns to promote implants to consumers. But how can patients objectively evaluate the qualifications of a dentist to perform implant surgery?
OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration (FDA) in December, 2011. The FDA has completed its review and has notified OptiNose that the studies under this IND may proceed. The Company will initiate Phase III trials in adults with acute migraine with or without aura utilizing its novel intranasal technology.
Solvay Pharmaceuticals announced today that it has obtained European marketing approval for its new virosomal influenza vaccine: INVIVAC®.
Authentidate Holding Corp., a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced that it received a deficiency notification from the Nasdaq Stock Market dated May 26, 2010 as the result of Authentidate not complying with the $1 minimum closing bid price requirement of Nasdaq Listing Rule 5550(a)(2) during the consecutive 30 business day period from April 13, 2010 through May 25, 2010. This notification has no effect on the listing of the company's common stock at this time.
› Verified 2 days ago
Ms. Evangeline Benoit, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 Fax: 203-937-3845 | |
Mr. William Hancock, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 | |
Kimberly Ann Winslow, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 |